Get the Stockscreener App
9.53
1.38%
0.13
After Hours:
9.40
-0.13
-1.36%
Neogen Corp stock is traded at $9.53, with a volume of 1.91M.
It is up +1.38% in the last 24 hours and up +1.49% over the past month.
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
See More
Previous Close:
$9.40
Open:
$9.45
24h Volume:
1.91M
Relative Volume:
0.69
Market Cap:
$2.07B
Revenue:
$870.54M
Net Income/Loss:
$-608.78M
P/E Ratio:
-3.3979
EPS:
-2.8047
Net Cash Flow:
$4.09M
1W Performance:
-0.10%
1M Performance:
+1.49%
6M Performance:
+54.46%
1Y Performance:
+85.05%
1-Day Range:
$9.29
$9.58
1-Week Range:
$8.98
$9.6835
52-Week Range:
$4.5305
$11.43
Neogen Corp Stock (NEOG) Company Profile
Name
Neogen Corp
Sector
Industry
Phone
(517) 372-9200
Address
620 LESHER PLACE, LANSING
Compare NEOG vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NEOG
Neogen Corp
|
9.53 | 2.03B | 870.54M | -608.78M | 4.09M | -2.8047 |
ABT
Abbott Laboratories
|
89.46 | 163.10B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
294.73 | 123.10B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
80.00 | 105.15B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
56.50 | 86.87B | 20.62B | 3.56B | 3.66B | 2.3847 |
EW
Edwards Lifesciences Corp
|
83.98 | 47.44B | 6.30B | 1.07B | 1.34B | 1.8406 |
Neogen Corp Stock (NEOG) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-29-25 | Downgrade | William Blair | Outperform → Mkt Perform |
| Dec-19-24 | Initiated | Guggenheim | Buy |
| Jun-16-23 | Initiated | Wells Fargo | Overweight |
| Nov-22-22 | Upgrade | William Blair | Mkt Perform → Outperform |
| Jul-12-22 | Initiated | Piper Sandler | Neutral |
| May-23-19 | Initiated | Guggenheim | Neutral |
| Dec-05-17 | Resumed | ROTH Capital | Neutral |
| Jul-14-17 | Initiated | CL King | Neutral |
| Jun-05-14 | Initiated | William Blair | Mkt Perform |
| Mar-31-11 | Upgrade | Hilliard Lyons | Underperform → Neutral |
| Sep-25-09 | Reiterated | Roth Capital | Buy |
| Jul-22-09 | Reiterated | Roth Capital | Buy |
| Mar-20-09 | Reiterated | Roth Capital | Buy |
| Jan-07-09 | Reiterated | Roth Capital | Buy |
| Sep-25-08 | Reiterated | Roth Capital | Buy |
| Jan-04-08 | Reiterated | Roth Capital | Buy |
| Sep-28-07 | Reiterated | Roth Capital | Buy |
| Jul-25-07 | Reiterated | Roth Capital | Buy |
| Jul-09-07 | Reiterated | Roth Capital | Buy |
| May-08-07 | Initiated | Susquehanna Financial | Positive |
View All
Neogen Corp Stock (NEOG) Latest News
Vanguard Capital Management holds 11.16M shares in Neogen (NEOG) - Stock Titan
Vanguard Portfolio Management reports 12.9M Neogen shares (NEOG) on 13G - Stock Titan
Neogen (NASDAQ:NEOG) Stock Crosses Above Two Hundred Day Moving AverageShould You Sell? - MarketBeat
3 Reasons NEOG is Risky and 1 Stock to Buy Instead - Yahoo! Finance Canada
Is AOAC-Certified Rapid Listeria Test Altering The Investment Case For Neogen (NEOG)? - Sahm
NEOG Price Today: Neogen Corp. Stock Price, Quote & Chart | MEXC - MEXC Exchange
Neogen (NEOG) Achieves Certification for Rapid Listeria Testing Method - GuruFocus
Neogen’s Listeria Right Now™ Test Receives AOAC® Performance Tested Methods℠ Certification - Yahoo Finance
Crude Oil Surges 3%; Neogen Shares Fall After Q3 Results - Sahm
Round Rock Advisors LLC Purchases 131,684 Shares of Neogen Corporation $NEOG - MarketBeat
Neogen Corp stock (US6404911066): Is its animal health focus strong enough to unlock new upside? - AD HOC NEWS
Neogen Corporation 8-K SEC Filing April 20, 2026 – Key Entity Information, Trading Symbol, and Nasdaq Listing - Minichart
Neogen schedules investor tours at Lansing facility, updates on Petrifilm validation By Investing.com - Investing.com
Neogen to host investor tours as Petrifilm SKUs complete operational qualifications - TradingView
Neogen (NEOG) plans investor tours to showcase Petrifilm validation progress - Stock Titan
Neogen Corporation (NASDAQ:NEOG) Given Average Rating of "Hold" by Analysts - MarketBeat
Neogen (NEOG) Is Down 7.9% After Raising 2026 Revenue Guidance Amid Wider Net Loss And New CLO – Has The Bull Case Changed? - simplywall.st
5 Must-Read Analyst Questions From Neogen’s Q1 Earnings Call - Yahoo Finance
Neogen Corp. Opens with 5.61% Gain, Outperforming S&P 500's 2.51% Rise - Markets Mojo
CapEx per share of Neogen Corp – FWB:NG2 - TradingView — Track All Markets
NEOGEN (NEOG) Chief Legal Officer Stacey Evans files insider ownership report - Stock Titan
Neogen Reshapes Portfolio Around Food Safety With Divestitures And Job Cuts - Sahm
Neogen tops estimates as food safety segment drives growth - MSN
The Bull Case For Neogen (NEOG) Could Change Following Q3 Loss, Guidance Hike, Genomics Sale News - Yahoo Finance
Assessing Neogen (NEOG) Valuation After Earnings Beat And Higher Full Year Guidance - Yahoo Finance
Neogen (NASDAQ:NEOG) Downgraded by Wall Street Zen to Hold - MarketBeat
Neogen (NASDAQ:NEOG) Shares Down 6.9%Here's Why - MarketBeat
Neogen Corp at JPMorgan Healthcare Conference Transcript - GuruFocus
BlackBerry, Constellation Brands And 3 Stocks To Watch Heading Into Thursday - Sahm
Neogen Corporation (NASDAQ:NEOG) Q3 2026 Earnings Call Transcript - Insider Monkey
Inside Neogen Corp (NEOG): A Comprehensive SWOT Breakdown - GuruFocus
Neogen Corporation Q3 2026 10-Q Report: Financial Statements, Risk Factors & Management Discussion - Minichart
Neogen beats estimates on strong food safety growth By Investing.com - Investing.com Canada
Crude oil surges 3%; Neogen shares fall after Q3 results - MSN
William Blair reiterates Neogen stock rating citing execution improvements - Investing.com
Neogen Corp (NEOG) Q3 2026 Earnings Call Highlights: Navigating Growth and Challenges - GuruFocus
[10-Q] NEOGEN CORP Quarterly Earnings Report - Stock Titan
Neogen (NASDAQ:NEOG) Shares Gap DownShould You Sell? - MarketBeat
Neogen (NASDAQ:NEOG) Mixed Quarter Reshapes Market View In Nasdaq Composite - Kalkine Media
Neogen earnings beat by $0.03, revenue topped estimates By Investing.com - Investing.com South Africa
Neogen Q3 FY26 slides: Food Safety growth offsets Animal Safety decline - Investing.com
Neogen Corp reports results for the quarter ended February 28Earnings Summary - TradingView
Neogen (NEOG) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Neogen Q3 Earnings Call Highlights - MarketBeat
Neogen (NASDAQ:NEOG) Issues Quarterly Earnings Results - MarketBeat
Neogen (NEOG) Q3 2025 Earnings Call Transcript - The Globe and Mail
Earnings call transcript: Neogen beats Q3 2026 forecasts but stock dips - Investing.com
Neogen (NEOG) Q3 FY2026 Earnings: GAAP EPS -$0.08 misses -$0.05 - GuruFocus
Neogen Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2026 - marketscreener.com
Neogen stock tumbles. Why a guidance hike and earnings beat aren’t helping - MSN
NEOGEN CORP (NASDAQ:NEOG) Posts Q3 Beat but Cuts Outlook as Animal Safety Segment Slumps - ChartMill
Neogen Corp Stock (NEOG) Financials Data
Revenue
Net Income
Cash Flow
EPS
Neogen Corp Stock (NEOG) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Nassif Mikheal | CEO |
Jan 26 '26 |
Buy |
9.86 |
25 |
246 |
657 |
| Nassif Mikheal | CEO |
Feb 02 '26 |
Buy |
10.00 |
24 |
240 |
681 |
| Nassif Mikheal | CEO |
Jan 16 '26 |
Buy |
9.33 |
137 |
1,279 |
632 |
| Naemura David H. | Former CFO |
Dec 01 '25 |
Option Exercise |
5.98 |
12,912 |
77,214 |
93,936 |
| Nassif Mikheal | CEO |
Nov 03 '25 |
Buy |
6.25 |
177 |
1,106 |
495 |
| BOREL JAMES C | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
96,347 |
| CAPELLO JEFFREY D | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
32,502 |
| Green Ronald D | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
18,654 |
| Gupta Aashima | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
27,790 |
| RODRIGUEZ RAFAEL A | Director |
Oct 27 '25 |
Option Exercise |
6.19 |
1,777 |
11,000 |
20,821 |
0.57%
1.14%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):